-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

625. Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents: Poster II

Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Xiaoxian Zhao, PhD1, Darren C. Phillips, PhD2*, Andrew J. Souers, PhD3*, Juraj Bodo, PhD1*, Paul Tapang3*, Daniel H Albert, PhD4*, Lisa Durkin1* and Eric D. Hsi, MD5

1Laboratory Medicine, Robert J. Tomsich Pathology & Laboratory Medicine Institute. Cleveland Clinic, Cleveland, OH
2AbbVie, Inc., North Chicago, IL
3Oncology Discovery, AbbVie, Inc., North Chicago, IL
4AbbVie, North Chicago, IL
5Laboratory Medicine, Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH

Xing Zhao1*, Narendiran Rajasekaran, PhD2*, Uwe Reusch, PhD3*, Jens-Peter Marschner, MD3*, Martin Treder3* and Holbrook Kohrt, MD4

1Center for Clinical Sciences Research Stanford, Stanford University, Stanford, CA
2Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
3Affimed GmbH, Heidelberg, Germany
4Stanford University, Stanford, CA

Wei Chan, PhD1*, Thomas Theriault, PhD2*, Ronald Levy, MD3 and James Swartz, DSc4*

1Departement of Chemical Engineering, Stanford University, Stanford, CA
2Bullet Biotechnology, Inc, Menlo Park, CA
3Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
4Department of Chemical Engineering and Department of Bioengineering, Stanford University, Stanford, CA

Montreh Tavakkoli, MA1, Dong H. Lee, MD1*, Benjamin Durham, MD, PhD2*, Stephen S. Chung, MD3 and Christopher Y. Park, M.D., Ph.D.4

1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY
2Memorial Sloan Kettering Cancer Center, New York, NY
3Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
4Pathology and Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY

Annika Nelde1,2*, Juliane S Stickel, MD2*, Daniel Johannes Kowalewski1*, Oliver Olaf Wolz1*, Lothar Kanz, MD2, Anton W. Langerak3*, Alice F. Muggen4*, Irina Bonzheim5*, Falko Fend, MD5*, Hans-Georg Rammensee, PhD1*, Stefan Stevanovic, PhD1* and Alexander N.R. Weber1*

1Department of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tuebingen, Germany
2Department of Hematology and Oncology, University of Tuebingen, Tuebingen, Germany
3Department of Immunology, Erasmus MC Rotterdam, Rotterdam, Netherlands
4Department of Immunology, Erasmus MC Rotterdam, 3015 CN Rotterdam, Rotterdam, Netherlands
5Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany

Dirk Daelemans, PhD1*, Eline Boons1*, Els Vanstreels1*, Maarten Jacquemyn1*, Tatiane C Nogueira1*, Jasper E Neggers1*, Thomas Vercruysse1*, Joost van den Oord2*, Sharon Tamir3*, Michael Kauffman, MD, PhD4, Sharon Shacham4*, Yosef Landesman, PhD3*, Robert Snoeck1*, Christophe Pannecouque1* and Graciela Andrei1*

1KU Leuven, Department of Microbiology and Immunology, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Leuven, Belgium
2KU Leuven, Department of Imaging and Pathology, Translational Cell & Tissue Research, Rega Institute for Medical Research, Leuven, Belgium
3Karyopharm Therapeutics Inc., Newton, MA
4Karyopharm Therapeutics, Inc, Newton, MA

Kerry A. Rogers, MD1, Dalia El-Gamal, PhD2, Harrington K. Bonnie, DVM3*, Hing A. Zachary, BS4*, Goettl M. Virginia, DVM, PhD1*, Mantel Rose1*, Lisa L. Smith, MS2*, Lianbo Yu, PhD5*, Amy J. Johnson, PhD2, John C. Byrd, MD2, Rosa Lapalombella, PhD2 and Jennifer A. Woyach, MD2

1Division of Hematology, The Ohio State University, Columbus, OH
2Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
3Department of Veterinary Biosciences, The Ohio State University, Columbus, OH
4Physician Scientist Training Program, The Ohio State University, Columbus, OH
5Center for Biostatistics, Department of Bioinformatics, The Ohio State University, Columbus, OH

Frank C. Passero Jr., MD1*, Ravi Dashnamoorthy, PhD2, Afshin Beheshti, PhD2*, Lynn Hlatky, PhD3*, Nassera Abermil, MS, PharmD3*, Michael E Coyle, MD1, Jaya Sharma, MD, MBBS1 and Andrew M. Evens, DO, MSc4

1Division of Hematology/Oncology, Tufts Medical Center, Boston, MA
2Molecular Oncology Research Institute, Tufts Medical Center, Boston, MA
3Tufts Medical Center, Boston
4Tufts Medical Center Cancer Center, Boston, MA

Aneel Paulus, MD, MS1, Kasyapa S. Chitta, PhD1, Sharoon Akhtar, MPhil2*, Hassan Yousaf3*, Davitte Cogen3*, Shireen Vali4*, Ansu Kumar5*, Neeraj Kumar Singh5*, Taher Abbasi4*, James M. Foran, MD6, Candido E. Rivera, MD7, Taimur Sher, MD8*, Vivek Roy, MD9, Sikander Ailawadhi, MD10 and Asher Alban Chanan-Khan, MD10

1Cancer Biology, Mayo Clinic, Jacksonville, FL
2Department of Cancer Biology, Mayo Clinic, Jacksonville, FL
3Mayo Clinic, Jacksonville, FL
4Cellworks Research India Ltd., Bangalore, India
5Cellworks Group, Inc., San Jose, CA
6Mayo Clinic Cancer Center, Jacksonville, FL
7Hematology/Oncology, Mayo Clinic, Jacksonville, FL
8Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL
9Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL
10Division of Hematology & Oncology, Mayo Clinic, Jacksonville, FL

Weiyun Ai, MD, PhD1, Chen-Yen Yang, Ph.D.2*, Razan Faraj2*, Taha Rakhshandhroo, BSc3*, Shervin Afghani, BSc2*, Laura Pincus, MD2*, Sourav Bandyopadhyay, PhD2* and Frank McCormick, PhD, FRS4*

1Department of Medicine-Hematology/Oncology, University of California at San Francisco, San Francisco, CA
2UCSF, San Francisco, CA
3University of California, San Diego, San Diego
4UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

Jonathan Scott Rink, Ph.D.1*, Shuo Yang2*, Osman Cen3*, Fei Ying4*, Young Kwang Chae, MD, MPH3, Denise Scholtens3*, Jonathan Moreira, MD5*, Amy Chadburn, MD6, Leo I. Gordon, MD4 and Colby Shad Thaxton3*

1Department of Urology, Northwestern University, Chicago, IL
2Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago
3Northwestern University, Chicago, IL
4Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago, IL
5Department of Medicine, Northwestern University - Feinberg School of Medicine, Chicago, IL
6Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY

Elisabeth Höring1*, German Ott, MD2*, Christine Bayha3*, Kleih Markus3*, Matthias C. Voehringer, MD4, Heiko van Der Kuip3* and Walter E. Aulitzky, MD5

1Robert Bosch Hospital, Stuttgart, Germany
2Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany
3IKP Stuttgart, Stuttgart, Germany
4Robert Bosch Kramkenhaus, Onkologie, Stuttgart, Germany
5Robert-Bosch-Krankenhaus, Stuttgart, Germany

Anita G Seto, PhD*, Xuan T Beatty, BS*, Linda A Pestano, PhD*, Brent A Dickinson, BA*, Marshelle S Warren, MD*, David M Rodman, MD* and Aimee L Jackson, PhD*

miRagen Therapeutics, Boulder, CO

Ran Wu, Ph.D.1*, Sheng Guo1*, Jie Cai, PhD2*, Xuesong Huang1*, Jie Yang1*, Jean-Pierre Wery1* and Henry Qi-xiang Li, PhD1

1Crown Bioscience, Santa Clara
2Crown Bioscience, Santa Clara, CA

Shuo Yang1*, Bo Ding2*, Fei Ying3*, Jana Svetlichnaya2*, Austin Tom3*, Sheila Prachand4*, Yanzhuang Wang5* and Leo I Gordon, MD, FACP6

1Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago
2Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago
3Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago, IL
4Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago, IL
5University of Michigan, Ann Arbor, MI
6Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center, Chicago, IL

Juan J Gu, PhD1*, Qunling Zhang, MD, PhD1,2*, Cory Mavis, MSc1*, Myron S. Czuczman, MD1,3 and Francisco J. Hernandez-Ilizaliturri, MD1

1Departments of Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, NY
2Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
3Celegene, Smmit, NJ

John M. Timmerman, MD1, Kristopher K Steward, PhD2,3*, Reiko E Yamada4*, Patricia A Young, MD1*, Dena M. Minning, MD, PhD3*, Raj K Sachdev, PhD2,3*, Michael J Gresser, PhD2,3*, Sanjay D Khare, PhD2,3* and Sherie L Morrison, PhD4*

1Division of Hematology & Oncology, University of California, Los Angeles, Los Angeles, CA
2ImmunGene, Inc., Camarillo, CA
3Valor Biotherapeutics, LLC, Dallas, TX
4University of California, Los Angeles, Los Angeles, CA

Xing Zhao1*, Narendiran Rajasekaran, PhD2*, Uwe Reusch, PhD3*, Michael Weichel3*, Kristina Ellwanger3*, Jens-Peter Marschner, MD3*, Martin Treder3* and Holbrook Kohrt, MD4

1Center for Clinical Sciences Research Stanford, Stanford University, Stanford, CA
2Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
3Affimed GmbH, Heidelberg, Germany
4Stanford University, Stanford, CA

*signifies non-member of ASH